UMC01
/ Ever Supreme Bio Tech
- LARVOL DELTA
Home
Next
Prev
1 to 11
Of
11
Go to page
1
August 08, 2025
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=14 | Active, not recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular • Ischemic stroke
August 08, 2025
UMSC01: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
(clinicaltrials.gov)
- P1/2 | N=41 | Recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Trial completion date: Dec 2026 ➔ Oct 2028 | Trial primary completion date: Dec 2026 ➔ Oct 2028
Trial completion date • Trial primary completion date • CNS Disorders • Multiple Sclerosis • IFNB1
September 20, 2024
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=14 | Recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Trial completion date: Dec 2024 ➔ Dec 2025 | Trial primary completion date: Dec 2024 ➔ Dec 2025
Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
August 28, 2024
UMSC01: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19
(clinicaltrials.gov)
- P1/2 | N=75 | Active, not recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Trial completion date: Dec 2023 ➔ Dec 2025 | Trial primary completion date: Dec 2023 ➔ Dec 2025
Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • CRP
August 14, 2023
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=14 | Recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Dec 2023 ➔ Dec 2024
Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
May 10, 2023
UMSC01: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
(clinicaltrials.gov)
- P1/2 | N=41 | Recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2022 ➔ Jun 2023
Enrollment open • Trial initiation date • CNS Disorders • Multiple Sclerosis
September 08, 2022
UMSC01: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
(clinicaltrials.gov)
- P1/2 | N=41 | Not yet recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd.
New P1/2 trial • CNS Disorders • Multiple Sclerosis
September 08, 2022
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction
(clinicaltrials.gov)
- P1 | N=10 | Completed | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ Dec 2021
Trial completion • Trial completion date • Cardiovascular • Myocardial Infarction
August 27, 2022
First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction.
(PubMed, Front Cardiovasc Med)
- "This pilot study shows that combined IC and IV transplantation of UMSC01 in STEMI patients with impaired LVEF appears to be safe, feasible, and potentially beneficial in improving heart function. Further phase 2 studies are required to explore the effectiveness of dual-route transplantation of UMSC01 in STEMI patients."
Journal • P1 data • Cardiovascular • Inflammation • Myocardial Infarction • Transplantation
March 23, 2022
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=14 | Recruiting | Sponsor: Ever Supreme Bio Technology Co., Ltd. | Trial completion date: Sep 2022 ➔ Dec 2023 | Trial primary completion date: Jul 2022 ➔ Dec 2023
Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
June 17, 2020
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke
(clinicaltrials.gov)
- P1; N=14; Recruiting; Sponsor: Ever Supreme Bio Technology Co., Ltd.
Clinical • New P1 trial • Cardiovascular • Ischemic stroke • Reperfusion Injury
1 to 11
Of
11
Go to page
1